Advertisement
Singapore markets open in 1 hour 19 minutes
  • Straits Times Index

    3,293.13
    +20.41 (+0.62%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • Dow

    38,460.92
    -42.77 (-0.11%)
     
  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     
  • Bitcoin USD

    64,140.34
    -2,306.56 (-3.47%)
     
  • CMC Crypto 200

    1,386.75
    -37.35 (-2.62%)
     
  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     
  • Gold

    2,327.90
    -10.50 (-0.45%)
     
  • Crude Oil

    82.80
    -0.01 (-0.01%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • Nikkei

    38,460.08
    +907.92 (+2.42%)
     
  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     
  • FTSE Bursa Malaysia

    1,571.48
    +9.84 (+0.63%)
     
  • Jakarta Composite Index

    7,174.53
    -7,110.81 (-49.78%)
     
  • PSE Index

    6,572.75
    +65.95 (+1.01%)
     

Revenue Spike Expected for GW Pharmaceuticals in 2019

Revenue Spike Expected for GW Pharmaceuticals in 2019

On its fiscal 2018 fourth-quarter earnings conference call, GW Pharmaceuticals (GWPH) announced the change of the end of its fiscal year from September 30 to the calendar year’s end on December 31. Analysts expect GW Pharmaceuticals to report revenue of $131.30 million in 2019, a YoY (year-over-year) rise of 930.86%. The company is also expected to report revenue of $421.71 million in 2020, a YoY rise of 221.18%.